InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,782.76
(
1.23%
)
US TECH 100
20,010.80
(
1.64%
)
Dow Jones
42,221.88
(
1.02%
)
Brent Oil
73.93
(
-1.94%
)
Bitcoin
73,771.77
(
6.43%
)
Post# of 253534
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: turtlepower post# 108931

Sunday, 11/14/2010 10:49:06 PM

Sunday, November 14, 2010 10:49:06 PM

Post# of 253534
Re: IMMU

How does this data stack up to Benlysta? There's reference to the data being stat sig, although no specific p-values are given. IMMU only has about a $250M market cap it appears (not sure about fully-diluted numbers) so if epratuzumab has the potential to be better than Benlysta, presumably IMMU may be worth a look.

Separately, any other small-cap biotechs targeting CD22?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up